TKPHF:OTCMKTS
Takeda Pharmaceutical Co Ltd
USD 36,75
arrow_downward
-0,68%(-0,25) 1D
1 Okt., 12:54:35 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TKPHF...
Open
USD 36,75
High
USD 36,75
Low
USD 36,75
Mkt. cap
57,81 mjd
Avg. vol.
1,27 k
Volume
25,10 k
52-wk high
USD 39,20
52-wk low
USD 26,33
Beta
-2,45
Shares outstanding
1,60 mjd
No. of employees
47 k
Open
USD 36,75
High
USD 36,75
Low
USD 36,75
Mkt. cap
57,81 mjd
Avg. vol.
1,27 k
Volume
25,10 k
52-wk high
USD 39,20
52-wk low
USD 26,33
Beta
-2,45
Shares outstanding
1,60 mjd
No. of employees
47 k
News stories
From web sources and news partners
TipRanks
·
3 uur gelede
Takeda Refines VPRIV Home Infusion Playbook With New EU Survey
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47 k
Founded12 Jun. 1781
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com